← All organizations
Highest phase reached
Phase 4
First clinical trial
May 1, 2014Last known activity
Oct 1, 2025
Timeline
No events for the selected filters.
Drugs by trial phase (19 distinct, 8 trials)
Phase 4 (6 own, 0 via acquisition)
Phase 3 (8 own, 0 via acquisition)
Other trials (5 own, 0 via acquisition)
Indications
Studied for
Recent trials (11)
- NCT07274215Lead sponsorN/AOct 1, 2025
- NCT06663293Sponsor investigatorN/AMar 10, 2022
- NCT06663293Lead sponsorN/AMar 10, 2022
- NCT04828564CollaboratorPhase 2/Phase 3Apr 30, 2021
- NCT04573153CollaboratorPhase 2/Phase 3Sep 21, 2020
- NCT04560049Reponsible party - principal investigatorPhase 4Jun 3, 2020
- NCT04560049Lead sponsorPhase 4Jun 3, 2020
- NCT04411433CollaboratorPhase 3May 8, 2020
- NCT02765217CollaboratorPhase 4Jun 1, 2016
- NCT02494466Lead sponsorPhase 4May 1, 2014
- NCT02494466Reponsible party - principal investigatorPhase 4May 1, 2014
Details
- Last known activity
- Oct 1, 2025